BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4229224)

  • 1. Blood fibrinolytic activity in acute glomerulonephritis and nephrotic syndrome.
    Laha PN; Agarwal RC
    J Assoc Physicians India; 1967 Apr; 15(4):151-4. PubMed ID: 4229224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormal coagulation and fibrinolytic activities in glomerulonephritis and nephrotic syndrome].
    Nakagawa M; Nishio A
    Nihon Rinsho; 1984 Jun; 42(6):1386-92. PubMed ID: 6482002
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various indices of the coagulant and anticoagulant systems of the blood in children with the nephrotic form of diffuse glomerulonephritis].
    Artemenko SP
    Pediatr Akus Ginekol; 1971; 6():16-7. PubMed ID: 5152379
    [No Abstract]   [Full Text] [Related]  

  • 4. Red cell survival time in acute glomerulonephritis and nephrotic syndrome.
    Mahakur AC; Patnaik SR; Misra SC; Panda RK; Panda RS; Rath RN; Rao CM
    J Assoc Physicians India; 1982 Mar; 30(3):131-2. PubMed ID: 7169419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of blood pyruvic acid estimation in evaluation of myocardial infarctionand renal disease.
    Agarwal RL; Raman R
    J Assoc Physicians India; 1970 Oct; 18(10):809-14. PubMed ID: 5503052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic significance of the state of the fibrinolytic system and evaluation of its functional possibilities in nephrotic syndrome].
    Poliantseva LR; Podorol'skaia LV; Nevraeva OG; Andreenko GV
    Ter Arkh; 1978; 50(11):84-91. PubMed ID: 725768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of plasma proteins in various renal diseases--with special reference to the changes in acute phase reactants of nephrotic syndrome (N.S.)].
    Ito A; Okura T
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1217-26. PubMed ID: 7166888
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein Z and vitamin K in kidney disease.
    Małyszko JS; Małyszko J; Skrzydlewska E; Pawlak K; Myśliwiec M
    Rocz Akad Med Bialymst; 2004; 49():197-200. PubMed ID: 15631343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome].
    Pisano L; Lombardi D; Spanò G
    Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet hypersensitivity in the nephrotic syndrome.
    Remuzzi G; Marchesi D; Mecca G; de Gaetano G; Silver M
    Proc Eur Dial Transplant Assoc; 1979; 16():487-94. PubMed ID: 548992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on plasma active and inactive renins in patients with nephrotic syndrome. Part II. Plasma active and inactive in glomerulonephritis with and without nephrotic syndrome (author's transl)].
    Tsai TJ
    Taiwan Yi Xue Hui Za Zhi; 1981 Jun; 80(6):592-9. PubMed ID: 7033441
    [No Abstract]   [Full Text] [Related]  

  • 13. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV; Sokolovskaia IV; Riaposova IK; Poliantseva LR
    Ter Arkh; 1982; 54(7):57-61. PubMed ID: 7135225
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of beta 1c globulin in the blood serum of children with diseases of the kidneys.
    Hager-Malecka B; Szczepański Z; Kobierska-Szczepańska A
    Arch Immunol Ther Exp (Warsz); 1968; 16(6):921-6. PubMed ID: 4178558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation study in renal disease].
    Saito S; Takahashi K; Sakuragawa N
    Rinsho Byori; 1987 Sep; 35(9):988-91. PubMed ID: 3430775
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uricemia in the pediatric age. II. In kidney diseases].
    Castello D; Rosmino GC; Baroncelli PG; Ghidella G
    Minerva Pediatr; 1968 Jan; 20(2):69-72. PubMed ID: 5737178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrophoresis of glycoproteins in urine and serum in some renal diseases].
    Bryla R
    Pol Tyg Lek; 1967 Aug; 22(32):1213-6. PubMed ID: 6056120
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.